SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-146526
Filing Date
2024-05-24
Accepted
2024-05-24 07:30:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d834394d424b5.htm 424B5 5715
2 GRAPHIC g834394g0523205824679.jpg GRAPHIC 6565
  Complete submission text file 0001193125-24-146526.txt   16077
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266605 | Film No.: 24980804
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)